Jennison Associates LLC Invitae Corp Transaction History

Jennison Associates LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$2.13 - $9.01 $279,852 - $1.18 Million	131,386 Added 71.71%	314,605 $768,000
Q1 2022 May 11, 2022	BUY	$6.28 - $15.59 $719,223 - $1.79 Million	114,526 Added 166.72%	183,219 $1.46 Million
Q4 2021 Feb 08, 2022	BUY	$14.7 - $28.67 $1.01 Million - $1.97 Million	68,693 New	68,693 $1.05 Million
Q3 2020 Nov 04, 2020	SELL	$28.43 - $44.67 $11.2 Million - $17.5 Million	-392,396 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$11.71 - $30.29 $23,127 - $59,822	1,975 Added 0.51%	392,396 $11.9 Million

Q1 2020 May 06, 2020	SELL	$7.64 - $27.5 $14,791 - $53,240	-1,936 Reduced 0.49%	390,421 $5.34 Million
Q4 2019 Feb 07, 2020	BUY	$15.02 - $20.57 $42,882 - $58,727	2,855 Added 0.73%	392,357 $6.33 Million
Q3 2019 Nov 08, 2019	SELL	$18.85 - $27.5 $489,232 - $713,735	-25,954 Reduced 6.25%	389,502 $7.51 Million
Q2 2019 Aug 06, 2019	BUY	$17.37 - $26.27 $7.22 Million - $10.9 Million	415,456 New	415,456 $0

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.